A new trial assessing the ability of COYA 302 to slow the progression of ALS will enroll up to 120 patients at sites in the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback